Skip to content

    Cervical Cancer Health Center

    Medical Reference Related to Cervical Cancer

    1. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - About This PDQ Summary

      About PDQPhysician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.Purpose of This SummaryThis PDQ cancer information summary has current

    2. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Stage I Endometrial Cancer

      Standard treatment options: A total hysterectomy and bilateral salpingo-oophorectomy should be done if the tumor: Is well or moderately differentiated.Involves the upper 66% of the corpus.Has negative peritoneal cytology.Is without vascular space invasion.Has less than a 50% myometrial invasion.Selected pelvic lymph nodes may be removed. If they are negative, no postoperative treatment is indicated. Postoperative treatment with a vaginal cylinder is advocated by some clinicians.[1]For all other cases and cell types, a pelvic and selective periaortic node sampling should be combined with the total hysterectomy and bilateral salpingo-oophorectomy, if there are no medical or technical contraindications. One study found that node dissection per se did not significantly add to the overall morbidity from hysterectomy.[2] While the radiation therapy will reduce the incidence of local and regional recurrence, improved survival has not been proven and toxic effects are

    3. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Treatment Options for Gestational Trophoblastic Disease

      A link to a list of current clinical trials is included for each treatment section. For some types of gestational trophoblastic disease, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.Hydatidiform MolesTreatment of a hydatidiform mole may include the following:Surgery (Dilatation and curettage with suction evacuation) to remove the tumor.After surgery, beta human chorionic gonadotropin (β-hCG) blood tests are done every week until the β-hCG level returns to normal. Patients also have follow-up doctor visits monthly for up to 6 months. If the level of β-hCG does not return to normal or increases, it may mean the hydatidiform mole was not completely removed and it has become cancer. Pregnancy causes β-hCG levels to increase, so your doctor will ask you not to become pregnant until follow-up is finished.For disease that remains after surgery, treatment is usually chemotherapy.Check for U.S. clinical

    4. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Get More Information From NCI

      Call 1-800-4-CANCERFor more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer. Write to usFor more information from the NCI, please write to this address:NCI Public Inquiries Office9609 Medical Center Dr. Room 2E532 MSC 9760Bethesda, MD 20892-9760Search the NCI Web siteThe NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support

    5. Cervical Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Stage II Uterine Sarcoma

      Standard treatment options:Surgery (total abdominal hysterectomy, bilateral salpingo-oophorectomy, and pelvic and periaortic selective lymphadenectomy).Surgery plus pelvic radiation therapy.Surgery plus adjuvant chemotherapy.Surgery plus adjuvant radiation therapy (EORTC-55874).In a nonrandomized, Gynecologic Oncology Group study in patients with stage I and II carcinosarcomas, those who had pelvic radiation therapy had a significant reduction of recurrences within the radiation treatment field but no alteration in survival.[1] One nonrandomized study that predominantly included patients with carcinosarcomas appeared to show benefit for adjuvant therapy with cisplatin and doxorubicin.[2]Current Clinical TrialsCheck for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with stage II uterine sarcoma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.General information about clinical

    6. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Stage Information for Gestational Trophoblastic Disease

      Hydatidiform Mole (HM)HM (molar pregnancy) is disease limited to the uterine cavity. Gestational Trophoblastic NeoplasiaDefinitions: FIGOThe Féderation Internationale de Gynécologie et d'Obstétrique (FIGO) and the American Joint Committee on Cancer (AJCC) have designated staging to define gestational trophoblastic neoplasia; the FIGO system is most commonly used.[1,2] Some tumor registrars encourage the recording of staging in both systems.FIGO staging system (and modified World Health Organization [WHO] prognostic scoring system)The FIGO staging system is as follows:[1]Table 1. Gestational Trophoblastic Neoplasia (GTN)a,bFIGO Anatomical StagingFIGO = Féderation Internationale de Gynécologie et d'Obstétrique; hCG = human chorionic gonadotropin; iu = international unit; WHO = World Health Organization.a Adapted from FIGO Committee on Gynecologic Oncology.[1]b To stage and allot a risk factor score, a patient's diagnosis is allocated to a stage as

    7. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - To Learn More About Gestational Trophoblastic Disease

      For more information from the National Cancer Institute about gestational trophoblastic tumors and neoplasia, see the following:Gestational Trophoblastic Disease Home PageDrugs Approved for Gestational Trophoblastic DiseaseMetastatic CancerFor general cancer information and other resources from the National Cancer Institute, see the following:What You Need to Know About™ CancerUnderstanding Cancer Series: CancerCancer StagingChemotherapy and You: Support for People With CancerRadiation Therapy and You: Support for People With CancerCoping with Cancer: Supportive and Palliative CareQuestions to Ask Your Doctor About CancerCancer LibraryInformation For Survivors/Caregivers/Advocates

    8. Cervical Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Changes to This Summary (04 / 22 / 2014)

      The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.

    9. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Treatment Option Overview

      Patients with endometrial cancer who have localized disease are usually curable by hysterectomy and bilateral salpingo-oophorectomy. Best results are obtained with either of two standard treatments: hysterectomy or hysterectomy and adjuvant radiation therapy (when deep invasion of the myometrial muscle [50% of the depth] or grade 3 tumor with myometrial invasion is present). Results of two randomized trials on the use of external-beam radiation therapy (EBRT) in patients with stage I disease did not show improved survival but did show reduced locoregional recurrence (3%–4% vs. 12%–14% after 5–6 years' median follow-up, P 50% myometrial invasion or grade 3 with <50% myometrial invasion).[4]Vaginal cuff

    10. Endometrial Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - nci_ncicdr0000304518-nci-header

      This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Cervical Cancer Screening

    Displaying 71 - 80 of 159 Articles << Prev Page 4 5 6 7 8 9 10 11 12 13 Next >>

    Today on WebMD

    cancer cell
    HPV is the top cause. Find out more.
    doctor and patient
    Get to know the symptoms.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    Integrative Medicine Cancer Quiz
    QUIZ
    Lifestyle Tips for Depression Slideshow
    SLIDESHOW
     
    Screening Tests for Women
    Slideshow
    what is your cancer risk
    HEALTH CHECK